据安迅思能源10月17日消息称，bp宣布同意收购美国领先的可再生天然气(RNG)生产商古生能源公司，此举将扩大和加速其战略生物能源业务的增长。

此次协议收购将以33亿美元的现金以及约800万美元的净债务进行，并有待监管机构和古生能源公司股东的批准。

生物能源是bp计划在本十年快速增长的五大战略转型增长引擎之一。bp预计，到2025年，对转型增长业务的投资将达到其年度总资本支出的40%以上，并计划到2030年将这一比例提高到50%左右。

收购古生能源将扩大bp在美国沼气行业的影响力，增强其支持客户脱碳目标的能力，并推进其降低其所销售能源产品平均碳强度的目标。bp的目标是到2050年或更早将碳强度降至净零。

曹海斌 摘译自 安迅思能源

原文如下：

bp accelerates and expands in bioenergy, agreeing to buy Archaea Energy

In a move that will expand and accelerate the growth of its strategic bioenergy business, bp announced that it has agreed to acquire Archaea Energy Inc., a leading producer of renewable natural gas (RNG) in the US, said Hydrocarbonprocessing.

The agreed acquisition, which is subject to regulatory and Archaea shareholder approval, will be for USD3.3 B in cash, as well as around USD800 MM of net debt.

Bioenergy is one of five strategic transition growth engines that bp intends to grow rapidly through this decade. bp expects investment into its transition growth businesses to reach more than 40% of its total annual capital expenditure by 2025, aiming to grow this to around 50% by 2030.

Acquiring Archaea will expand bp’s presence in the US biogas industry, enhancing its ability to support customers’ decarbonization goals and also progressing its aim to reduce the average carbon intensity of the energy products it sells. bp aims to reduce that carbon intensity to net zero by 2050 or sooner.